Orange Biomed exchanged key insights with industry experts while presenting our latest innovation at the 85th Scientific Sessions of the American Diabetes Association (ADA), held June 20-23, 2025, in Chicago.
At the Consumer Electronics Show 2025, Orange Biomed showcased the OBM rapid A1c device, advancing healthcare with groundbreaking diabetes care innovation.
Diabetes care for patients accounts for 1 in 4 healthcare dollars spent in the U.S. A large part of these costs is spent on diabetes-associated comorbidities.
Stay informed about our launch and get exclusive updates straight to your inbox. Fill out the form below, and we’ll make sure you’re among the first to know when OBM rapid A1c test hits the market.
"*" indicates required fields
